Export

Budesonide + formoterol
Essential medicine status
General description

INN
Budesonide + formoterol
Medicine type
Chemical agent
EML status history
First added in 2017 (TRS 1006) for Asthma
Therapeutic equivalent for
Recommendations
Section
Antiasthmatic and medicines for chronic obstructive pulmonary disease
  • Respiratory > Inhalation > dry powder: 100 µg + 6 µg per dose; 200 µg + 6 µg per dose
Indications